Canfosfamide Hydrochloride

N/A

Report date: 2023/05/05 17:41:40
NME

Base Information

Drug NameCanfosfamide Hydrochloride
Drug Alias Name坎磷酰胺canfosfamidacanfosfamidecanfosfamidumTelcyta +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsFallopian Tube NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[15] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMabvax Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteTelik Inc
Active IndicationsN/A
Inactive IndicationsFallopian Tube NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[9] 

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG